Search

everythinglearnresearchcommunity

for

Search:↓

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

Overexpression of LRIG3 in skin causes hair loss.

EP 2 receptor is essential for heart repair by helping macrophages work properly.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Hairless protein reduces Msx2 gene activity, affecting hair follicle development.

rhKGF2 significantly promotes hair growth and follicle development.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

The NF-κB effector p65/RelA activates hair keratin genes, aiding hair formation.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ectodysplasin inhibits Wnt signaling to help form hair follicles.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

FLRG and follistatin have different roles in wound healing.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Androgen receptors help prostate cancer cells grow and resist drugs.

HR protein causes abnormal hair cycles by increasing Tgf-β2 and reducing miR-31.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

TRH stimulates human hair growth and extends the hair growth phase.

miR-29a-5p prevents the formation of early hair structures by targeting a gene important for hair growth and is regulated by a complex network involving lncRNA627.1.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

RC48 shows promise for treating certain advanced cancers, but more research is needed.